|
An innovative analytical platform to investigate the effect and toxicity of micro and nanoplastics (MNPs) combined with environmental contaminants on the risk of allergic disease in pre-clinical and clinical studies |
IMPTOX |
April 1, 2021 |
March 30, 2025 |
Risk and health impact assessment |
microplastic, nanoplastic, human exposure, allergic disease, toxicity |
|
Monitoring of the whole genome sequencing (WGS) data of SARS-CoV-2 genomes to identify variants and their impact on detection methods |
COVIPRIM_VAR2 |
February 1, 2021 |
December 31, 2021 |
Quality of laboratories , Transversal activities in applied genomics |
NGS, computational biology, bioinformatics, mutations, variants, database, disease outbreaks, performance evaluation, SARS-CoV-2, COVID-19, qPCR, disease transmission |
|
Linking of registers for COVID-19 vaccine surveillance |
LINK-VACC |
January 1, 2021 |
January 31, 2024 |
Epidemiology of infectious diseases, Healthcare-associated infections and antimicrobial resistance |
COVID-19, SARS-CoV-2, corona virus, vaccine, vaccinale effectiviteit, surveillance |
|
Unravelling the long-term and indirect health impact of the COVID-19 crisis in Belgium |
HELICON |
January 1, 2021 |
June 30, 2025 |
Lifestyle and chronic diseases , Epidemiology of infectious diseases |
health inequalities, health economics, delayed healthcare use, socio-demographic resilience, cohort study, excess mortality |
|
Development of a method to assess the diversity of SARS-CoV-2 circulating strains in Belgium |
COVIDDIVER |
January 1, 2021 |
January 1, 2022 |
Viral diseases, Cancer centre , Transversal activities in applied genomics |
ddPCR, epidemic, COVID-19, SARS-CoV-2, wastewater, clinical samples |
|
Development of a digital PCR method for accurate detection and quantification of SARS-CoV-2 |
DIGICOVID |
January 1, 2021 |
January 1, 2022 |
Viral diseases, Transversal activities in applied genomics, Enzootic, vector-borne and bee diseases |
ddPCR, epidemic, COVID-19, SARS-CoV-2, wastewater, clinical samples, surveillance |
|
Development of a digital PCR method for accurate detection and quantification of SARS-CoV-2 and its variants |
DIGICOVID_VAR |
January 1, 2021 |
January 1, 2022 |
Foodborne pathogens, Viral diseases, Transversal activities in applied genomics |
ddPCR, epidemic, COVID-19, SARS-CoV-2, wastewater, clinical samples, variants, surveillance |
|
Towards the development of a National Health Data Platform |
AHEAD |
January 1, 2021 |
June 30, 2023 |
Lifestyle and chronic diseases , Cancer centre |
health information system, health surveys, administrative data, data linkage, national health database |
|
Harmonised indicators for measuring progress toward more sustainable, healthier food systems |
INFORMAS 2.0 |
December 1, 2020 |
October 31, 2024 |
Lifestyle and chronic diseases |
non-communicable diseases, food environments, food systems, sustainability |
|
Understanding the dynamics and consequences of new psychoactive substances use in a rapidly changing (online) drug market |
SCANNER |
October 1, 2020 |
November 30, 2022 |
Lifestyle and chronic diseases |
NPS, new psychoactive substances, illicit drugs, drug use, influence legislation, ringtesting, proficiency testing, helplines and drug checking services, civil society organisations, fentanyl hotspots |
|
Strengthen the capacity of governments and researchers in the evaluation of public policies on healthy food environments in Francophone West Africa to prevent the triple burden of malnutrition |
NCDs-WAfrica |
October 1, 2020 |
September 30, 2023 |
Lifestyle and chronic diseases |
non-communicable diseases, low-middle income countries, food environments, nutrition policy, triple burden of malnutrition |
|
Joint Action on Implementation of Validated Best Practices in Nutrition in Europe |
Best-ReMaP |
October 1, 2020 |
September 30, 2023 |
Lifestyle and chronic diseases |
food reformulation, food marketing, Europe, food supply monitoring |
|
COVID-19-Barometer in general practices - version 2.0 |
COVID-19 BM 2.0 |
October 1, 2020 |
March 31, 2021 |
Health services research |
COVID-19, surveillance, médecine générale, soins de santé primaire |
|
Childhood Obesity Surveillance Initiative - Belgium |
COSI |
June 1, 2020 |
|
Lifestyle and chronic diseases |
overweight, obesity, monitoring, children |
|
Development and validation of a novel life course microsimulation model linking diet to non-communicable diseases |
Micro-NCDs |
April 1, 2020 |
March 31, 2024 |
Lifestyle and chronic diseases |
modelling, non-communicable diseases, diet quality, microsimulation |
|
VALidation of SARS-CORona Virus-2 assays |
VALCOR |
April 1, 2020 |
September 30, 2021 |
Cancer centre |
|
|
Context-Specific Interventions for Nutrition-Related Non-Communicable Diseases Prevention in East Africa |
RECAP |
April 1, 2020 |
March 31, 2023 |
Lifestyle and chronic diseases |
non-communicable diseases, low-middle income countries, food environments, nutrition policy, food marketing |
|
Monitoring the performance of detection methods for SARS-CoV-2 in clinical samples using sequencing data |
COVIPRIM |
April 1, 2020 |
December 31, 2020 |
Viral diseases, Quality of laboratories , Transversal activities in applied genomics |
|
|
Evaluation of the types, efficient use and health risks of application of silver-based biocides to provide antimicrobial properties to face masks applied during the COVID-19 crisis |
AgMask |
January 10, 2020 |
September 30, 2022 |
Chemical and physical health risks |
silver, biocide, face mask |
|
Exploring the evolutionary success of the antibiotic resistant Salmonella Kentucky ST198 |
KENTUCKY |
January 1, 2020 |
December 31, 2022 |
Bacterial diseases |
antimicrobial resistance, long-read sequencing, plasmid, mobile genetic elements |
|
Full-length sequencing to map and understand drivers and reservoirs of antimicrobial resistance |
FULL_FORCE |
January 1, 2020 |
June 30, 2022 |
Bacterial diseases |
antimicrobial resistance, long-read sequencing, plasmid, mobile genetic elements |
|
European regimen accelerator for Tuberculosis |
ERA4TB |
January 1, 2020 |
December 31, 2024 |
Bacterial diseases |
tuberculosis, multidrug-resistant TB, drugs, treatment |
|
Monitoring and mitigating environmental health inequalities |
ELLIS |
December 24, 2019 |
December 31, 2023 |
Lifestyle and chronic diseases , Risk and health impact assessment |
|
|
Investigation of resistance mechanisms in emerging pathogens with the 'OneHealth' concept as missing link |
MissingLink |
December 16, 2019 |
March 16, 2024 |
Foodborne pathogens, Mycology and aerobiology |
antimicrobial resistance, OneHealth, azole-resistance, Aspergillus fumigatus, Klebsiella pneumoniae |
|
Determination of propylene glycol levels in foodstuffs and exposure assessment for the Belgian population |
PROPYLENE GLYCOL DRINKS |
December 1, 2019 |
January 22, 2021 |
Organic contaminants and additives |
food additives, Propane-1, 2-diol (propylene glycol), E1520, non-alcoholic drinks, exposure assessment |
|
Co-creative and geographical approaches to tackle socioeconomic disparities in health enhancing lifestyle |
CIVISANO |
November 14, 2019 |
December 31, 2023 |
Risk and health impact assessment, Lifestyle and chronic diseases |
health inequalities, co-creation, community based participatory research (CBPR), Geographic Information Systems (GIS), Socioeconomic status, obesity, physical activity, healthy eating, obesogenic environments |
|
Occurrence of tropane alkaloids in foodstuffs and risks for the Belgian consumer |
TROPAL |
October 1, 2019 |
June 30, 2021 |
Organic contaminants and additives |
tropane alkaloids, LC-MS/MS, exposure assessment, GIS |
|
Development of innovative methodological approaches for the study of complex samples: application to the analysis of cannabis and derived products |
CANNAL |
October 1, 2019 |
October 1, 2024 |
Medicines and health products |
|
|
Transcriptional Response for Antimicrobial Resistance detection in TB |
TRACeR-TB |
October 1, 2019 |
December 31, 2021 |
Bacterial diseases |
Mycobacterium Tuberculosis (Mtb), diagnostics, drug resistance, drug resistance testing, transcriptional response |
|
Contribution of excessive weight status to the social impact of non-communicable diseases, multimorbidity and disability in Belgium: past, present, and future |
WaIST |
September 1, 2019 |
December 31, 2023 |
Lifestyle and chronic diseases |
Disability-Adjusted Life Years, Health Impact Assessment, Modelling and forecasting, Environmental health determinants, Cardiovascular diseases, Diabetes, cancer, Disability, Multimorbidity |
